ATP Binding to p97/VCP D1 Domain Regulates Selective Recruitment of Adaptors to Its Proximal N-Domain

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Chia, Wei Sheng ^a   Chia, Diana Xueqi ^a   Rao, Feng ^a,c   Bar Nun, Shoshana ^b   Geifman Shochat, Susana ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b TEL AVIV UNIVERSITY   (Israel)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ADENOSINE TRIPHOSPHATE; PROTEIN P47; PROTEIN P97; VALOSIN CONTAINING PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN NUCLEIC ACID INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STABILITY; PROTEIN UNFOLDING; REACTION TIME; REGULATORY MECHANISM; RNA BINDING; THERMOSTABILITY;

ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; BINDING, COMPETITIVE; CHROMATOGRAPHY, AFFINITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUOROMETRY; HYDROLYSIS; KINETICS; NUCLEAR PROTEINS; PROTEIN CONFORMATION; SURFACE PLASMON RESONANCE;

EID: 84870704332     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050490     Document Type: Article

References (63)

1. Brunger AT, DeLaBarre B, Davies JM, Weis WI, (2009) X-ray structure determination at low resolution. Acta Crystallogr D Biol Crystallogr 65: 128-133.
2. DeLaBarre B, Christianson JC, Kopito RR, Brunger AT, (2006) Central pore residues mediate the p97/VCP activity required for ERAD. Mol Cell 22: 451-462.
3. Dreveny I, Kondo H, Uchiyama K, Shaw A, Zhang X, et al. (2004) Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47. EMBO J 23: 1030-1039.
4. Huyton T, Pye VE, Briggs LC, Flynn TC, Beuron F, et al. (2003) The crystal structure of murine p97/VCP at 3.6A. J Struct Biol 144: 337-348.
5. Peters JM, Harris JR, Lustig A, Muller S, Engel A, et al. (1992) Ubiquitous soluble Mg(2+)-ATPase complex. A structural study. J Mol Biol 223: 557-571.
6. Rouiller I, Butel VM, Latterich M, Milligan RA, Wilson-Kubalek EM, (2000) A major conformational change in p97 AAA ATPase upon ATP binding. Mol Cell 6: 1485-1490.
7. Niwa H, Ewens CA, Tsang C, Yeung HO, Zhang X, et al. (2012) The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP. J Biol Chem 287: 8561-8570.
8. Wang Q, Song C, Li CC, (2003) Hexamerization of p97-VCP is promoted by ATP binding to the D1 domain and required for ATPase and biological activities. Biochem Biophys Res Commun 300: 253-260.
9. Thoms S, (2002) Cdc48 can distinguish between native and non-native proteins in the absence of cofactors. FEBS Lett 520: 107-110.
10. Pye VE, Dreveny I, Briggs LC, Sands C, Beuron F, et al. (2006) Going through the motions: the ATPase cycle of p97. J Struct Biol 156: 12-28.
11. Song C, Wang Q, Li CC, (2003) ATPase activity of p97-valosin-containing protein (VCP). D2 mediates the major enzyme activity, and D1 contributes to the heat-induced activity. J Biol Chem 278: 3648-3655.
12. Beuron F, Dreveny I, Yuan X, Pye VE, McKeown C, et al. (2006) Conformational changes in the AAA ATPase p97-p47 adaptor complex. EMBO J 25: 1967-1976.
13. Beuron F, Flynn TC, Ma J, Kondo H, Zhang X, et al. (2003) Motions and negative cooperativity between p97 domains revealed by cryo-electron microscopy and quantised elastic deformational model. J Mol Biol 327: 619-629.
14. Davies JM, Brunger AT, Weis WI, (2008) Improved structures of full-length p97, an AAA ATPase: implications for mechanisms of nucleotide-dependent conformational change. Structure 16: 715-726.
15. Davies JM, Tsuruta H, May AP, Weis WI, (2005) Conformational changes of p97 during nucleotide hydrolysis determined by small-angle X-Ray scattering. Structure 13: 183-195.
16. DeLaBarre B, Brunger AT, (2005) Nucleotide dependent motion and mechanism of action of p97/VCP. J Mol Biol 347: 437-452.
17. Rouiller I, DeLaBarre B, May AP, Weis WI, Brunger AT, et al. (2002) Conformational changes of the multifunction p97 AAA ATPase during its ATPase cycle. Nat Struct Biol 9: 950-957.
18. Halawani D, Latterich M, (2006) p97: The cell's molecular purgatory? Mol Cell 22: 713-717.
19. Dai RM, Chen E, Longo DL, Gorbea CM, Li CC, (1998) Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha. J Biol Chem 273: 3562-3573.
20. Dalal S, Rosser MF, Cyr DM, Hanson PI, (2004) Distinct roles for the AAA ATPases NSF and p97 in the secretory pathway. Mol Biol Cell 15: 637-648.
21. Ghislain M, Dohmen RJ, Levy F, Varshavsky A, (1996) Cdc48p interacts with Ufd3p, a WD repeat protein required for ubiquitin-mediated proteolysis in Saccharomyces cerevisiae. EMBO J 15: 4884-4899.
22. Jentsch S, Rumpf S, (2007) Cdc48 (p97): a "molecular gearbox" in the ubiquitin pathway? Trends Biochem Sci 32: 6-11.
23. Bar-Nun S, (2005) The role of p97/Cdc48p in endoplasmic reticulum-associated degradation: from the immune system to yeast. Curr Top Microbiol Immunol 300: 95-125.
24. Rabinovich E, Kerem A, Frohlich KU, Diamant N, Bar-Nun S, (2002) AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol Cell Biol 22: 626-634.
25. Ye Y, Meyer HH, Rapoport TA, (2001) The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 414: 652-656.
26. Elkabetz Y, Shapira I, Rabinovich E, Bar-Nun S, (2004) Distinct steps in dislocation of luminal endoplasmic reticulum-associated degradation substrates: roles of endoplamic reticulum-bound p97/Cdc48p and proteasome. J Biol Chem 279: 3980-3989.
27. Vale RD, (2000) AAA proteins. Lords of the ring. J Cell Biol 150: F13-19.
28. Haines DS, (2010) p97-containing complexes in proliferation control and cancer: emerging culprits or guilt by association? Genes Cancer 1: 753-763.
29. Hirabayashi M, Inoue K, Tanaka K, Nakadate K, Ohsawa Y, et al. (2001) VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ 8: 977-984.
30. Ishigaki S, Hishikawa N, Niwa J, Iemura S, Natsume T, et al. (2004) Physical and functional interaction between Dorfin and Valosin-containing protein that are colocalized in ubiquitylated inclusions in neurodegenerative disorders. J Biol Chem 279: 51376-51385.
31. Kobayashi T, Manno A, Kakizuka A, (2007) Involvement of valosin-containing protein (VCP)/p97 in the formation and clearance of abnormal protein aggregates. Genes Cells 12: 889-901.
32. Matsumoto M, Yada M, Hatakeyama S, Ishimoto H, Tanimura T, et al. (2004) Molecular clearance of ataxin-3 is regulated by a mammalian E4. EMBO J 23: 659-669.
33. Mizuno Y, Hori S, Kakizuka A, Okamoto K, (2003) Vacuole-creating protein in neurodegenerative diseases in humans. Neurosci Lett 343: 77-80.
34. Ju JS, Weihl CC, (2010) Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy. Hum Mol Genet 19: R38-45.
35. Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, et al. (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36: 377-381.
36. Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, et al. (2010) Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68: 857-864.
37. Braun S, Matuschewski K, Rape M, Thoms S, Jentsch S, (2002) Role of the ubiquitin-selective CDC48(UFD1/NPL4)chaperone (segregase) in ERAD of OLE1 and other substrates. EMBO J 21: 615-621.
38. Rape M, Hoppe T, Gorr I, Kalocay M, Richly H, et al. (2001) Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone. Cell 107: 667-677.
39. Madsen L, Seeger M, Semple CA, Hartmann-Petersen R, (2009) New ATPase regulators-p97 goes to the PUB. Int J Biochem Cell Biol 41: 2380-2388.
40. Yeung HO, Kloppsteck P, Niwa H, Isaacson RL, Matthews S, et al. (2008) Insights into adaptor binding to the AAA protein p97. Biochem Soc Trans 36: 62-67.
41. Bays NW, Hampton RY, (2002) Cdc48-Ufd1-Npl4: stuck in the middle with Ub. Curr Biol 12: R366-371.
42. Kondo H, Rabouille C, Newman R, Levine TP, Pappin D, et al. (1997) p47 is a cofactor for p97-mediated membrane fusion. Nature 388: 75-78.
43. Meyer HH, Shorter JG, Seemann J, Pappin D, Warren G, (2000) A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways. EMBO J 19: 2181-2192.
44. Bruderer RM, Brasseur C, Meyer HH, (2004) The AAA ATPase p97/VCP interacts with its alternative co-factors, Ufd1-Npl4 and p47, through a common bipartite binding mechanism. J Biol Chem 279: 49609-49616.
45. Tang WK, Li D, Li CC, Esser L, Dai R, et al. (2010) A novel ATP-dependent conformation in p97 N-D1 fragment revealed by crystal structures of disease-related mutants. EMBO J 29: 2217-2229.
46. DeLaBarre B, Brunger AT, (2003) Complete structure of p97/valosin-containing protein reveals communication between nucleotide domains. Nat Struct Biol 10: 856-863.
47. Zhang X, Shaw A, Bates PA, Newman RH, Gowen B, et al. (2000) Structure of the AAA ATPase p97. Mol Cell 6: 1473-1484.
48. Dreveny I, Pye VE, Beuron F, Briggs LC, Isaacson RL, et al. (2004) p97 and close encounters of every kind: a brief review. Biochem Soc Trans 32: 715-720.
49. Kloppsteck P, Ewens CA, Forster A, Zhang X, Freemont PS, (2011) Regulation of p97 in the ubiquitin-proteasome system by the UBX protein-family. Biochim Biophys Acta 1823: 125-129.
50. Bebeacua C, Forster A, McKeown C, Meyer HH, Zhang X, et al. (2012) Distinct conformations of the protein complex p97-Ufd1-Npl4 revealed by electron cryomicroscopy. Proc Natl Acad Sci U S A 109: 1098-1103.
51. Esaki M, Ogura T, (2010) ATP-bound form of the D1 AAA domain inhibits an essential function of Cdc48p/p97. Biochem Cell Biol 88: 109-117.
52. Ando T, Imamura H, Suzuki R, Aizaki H, Watanabe T, et al. (2012) Visualization and measurement of ATP levels in living cells replicating hepatitis C virus genome RNA. PLoS Pathog 8: e1002561.
53. Ataullakhanov FI, Vitvitsky VM, (2002) What determines the intracellular ATP concentration. Biosci Rep 22: 501-511.
54. Imamura H, Nhat KP, Togawa H, Saito K, Iino R, et al. (2009) Visualization of ATP levels inside single living cells with fluorescence resonance energy transfer-based genetically encoded indicators. Proc Natl Acad Sci U S A 106: 15651-15656.
55. Liemburg-Apers DC, Imamura H, Forkink M, Nooteboom M, Swarts HG, et al. (2011) Quantitative glucose and ATP sensing in mammalian cells. Pharm Res 28: 2745-2757.
56. Meyer HH, Kondo H, Warren G, (1998) The p47 co-factor regulates the ATPase activity of the membrane fusion protein, p97. FEBS Lett. 437: 255-257.
57. Lass A, McConnell E, Fleck K, Palamarchuk A, Wojcik C, (2008) Analysis of Npl4 deletion mutants in mammalian cells unravels new Ufd1-interacting motifs and suggests a regulatory role of Npl4 in ERAD. Exp Cell Res 314: 2715-2723.
58. Parihar MS, Brewer GJ, (2007) Mitoenergetic failure in Alzheimer disease. Am J Physiol Cell Physiol 292: C8-23.
59. Wallace DC, (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39: 359-407.
60. Indig FE, Partridge JJ, von Kobbe C, Aladjem MI, Latterich M, et al. (2004) Werner syndrome protein directly binds to the AAA ATPase p97/VCP in an ATP-dependent fashion. J Struct Biol 146: 251-259.
61. Chang YC, Hung WT, Chang HC, Wu CL, Chiang AS, et al. (2011) Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model. PLoS Genet 7: e1001288.
62. Bjorkelund H, Gedda L, Barta P, Malmqvist M, Andersson K, (2011) Gefitinib induces epidermal growth factor receptor dimers which alters the interaction characteristics with (1)(2)(5)I-EGF. PLoS One 6: e24739.
63. Niesen FH, Berglund H, Vedadi M, (2007) The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat Protocols 2: 2212-2221.